Actinium Completes Technology Transfer for Manufacturing of Its Lead Drug Candidate Iomaba -B

Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, has successfully transferred the technology for the manufacture of Iomaba -B , a drug being developed for therapeutic treatment of incurable blood cancers.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131219005219&newsLang=en&ndmConfigId=1000639&vnsId=41